ANGPTL6 and hepatocellular carcinoma: The combination of ANGPTL6 with AFP provided better diagnostic performance of preclinical HCC before clinical diagnosis (AUC 0.852, sensitivity 72.7%, specificity 87.5%, Fig. 7c).